AbCellera Biologics Inc. ABCL Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $8.32M-81.5% | $44.85M+401% | $8.96M-47.6% | $17.08M+303% | $4.24M-16.1% | ||
| $46.66M-6.8% | $50.09M-9.0% | $55.03M+40.3% | $39.21M-7.7% | $42.5M-7.8% | ||
| $12.33M— | —— | —— | —— | $19.07M— | ||
| $65.83M-10.4% | $73.44M-13.8% | $85.23M+27.8% | $66.67M-0.3% | $66.9M-14.0% | ||
| -$57.52M-101% | -$28.58M+62.5% | -$76.28M-53.8% | -$49.59M+20.9% | -$62.66M+13.9% | ||
| -691.7%-628pp | -63.7%+788pp | -851.8%-562pp | -290.2%+1,189pp | -1,479.6%-38.9pp | ||
| $7.98M-12.1% | $9.08M+20.9% | $7.51M-43.3% | $13.24M+36.8% | $9.68M-62.7% | ||
| -$49.54M-154% | -$19.5M+71.6% | -$68.77M-89.2% | -$36.34M+31.4% | -$52.98M-13.1% | ||
| -$6.37M+39.6% | -$10.55M+9.4% | -$11.65M-620% | -$1.62M+78.0% | -$7.36M+41.7% | ||
| -$43.17M-383% | -$8.95M+84.3% | -$57.12M-64.5% | -$34.73M+23.9% | -$45.62M-33.4% | ||
| -519.1%-499pp | -19.9%+618pp | -637.8%-435pp | -203.3%+874pp | -1,077.2%-400pp | ||
| -$0.14-367% | -$0.03+84.2% | -$0.19-58.3% | -$0.12+20.0% | -$0.15-36.4% | ||
| -$50.68M-125% | -$22.49M+68.3% | -$71.03M-61.0% | -$44.12M+23.0% | -$57.33M+18.9% | ||
| -609.5%-559pp | -50.1%+743pp | -793.2%-535pp | -258.2%+1,095pp | -1,353.7%+45.4pp | ||
| -$57.52M-101% | -$28.58M+62.5% | -$76.28M-53.8% | -$49.59M+20.9% | -$62.66M+13.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does AbCellera Biologics Inc.'s income statement data come from?
- Every line is extracted from AbCellera Biologics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.